KPMA fined for fair trade violations

Published: 2013-02-05 07:00:00

Updated: 2013-02-05 07:00:00

The Korea Pharmaceutical Manufacturers Association (KPMA) has been fined for threatening sanctions on its member companies over their attempts to supply extremely low-priced drugs to five national hospitals under the Korea Veterans Health Service (KVHS).

KPMA was fined 500 million won and orde...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK